Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 720385, 6 pages
http://dx.doi.org/10.1155/2014/720385
Clinical Study

Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma

Department of Ophthalmology and Visual Science, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan

Received 21 September 2014; Revised 9 November 2014; Accepted 9 November 2014; Published 19 November 2014

Academic Editor: Pai-Huei Peng

Copyright © 2014 Ryoko Igarashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Japan Glaucoma Society Glaucoma Diagnosis Guidelines Committee, “Glaucoma diagnosis guidelines,” vol. 116, no. 1, pp. 3–46, 2012 (Japanese). View at Google Scholar
  2. C. G. De Moraes, J. M. Liebmann, D. S. Greenfield, S. K. Gardiner, R. Ritch, and T. Krupin, “Risk factors for visual field progression in the low-pressure glaucoma treatment study,” The American Journal of Ophthalmology, vol. 154, no. 4, pp. 702–711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Krupin, J. M. Liebmann, D. S. Greenfield, R. Ritch, and S. Gardiner, “Low-pressure Glaucoma Treatment Study Group: a randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study,” The American Journal of Ophthalmology, vol. 151, no. 6, pp. 671–681, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Fukuchi, K. Wakai, K. Suda et al., “Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications,” Clinical Ophthalmology, vol. 4, no. 1, pp. 203–209, 2010. View at Google Scholar · View at Scopus
  5. T. Fukuchi, T. Yoshino, M. Seki et al., “Improvement of glaucoma medication and the follow-up intraocular pressure in primary open-angle glaucomatous eyes in Japan,” Folia Japonica de Ophthalmologica Clinica, vol. 4, no. 3, pp. 209–215, 2011 (Japanese). View at Google Scholar · View at Scopus
  6. I. Kaiserman, N. Kaiserman, S. Nakar, and S. Vinker, “The effect of combination pharmacotherapy on the prescription trends of glaucoma medications,” Journal of Glaucoma, vol. 14, no. 2, pp. 157–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kashiwagi, “Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy,” Japanese Journal of Ophthalmology, vol. 56, no. 4, pp. 339–345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Miyata, S. Amano, M. Sawa, and T. Nishida, “A novel grading method for superficial punctate keratopathy magnitude and its correction with corneal epithelial permeability,” Archives of Ophthalmology, vol. 121, no. 11, pp. 1537–1539, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Tomita, M. Araie, Y. Kitazawa, and S. Tsukahara, “A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients,” Eye, vol. 18, no. 10, pp. 984–989, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Ishibashi, N. Hirose, A. Tawara, and T. Kubota, “Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma,” Journal of Glaucoma, vol. 15, no. 5, pp. 354–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Quaranta, T. Pizzolante, I. Riva, A.-B. Haidich, A. G. P. Konstas, and W. C. Stewart, “Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma,” British Journal of Ophthalmology, vol. 92, no. 9, pp. 1227–1231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. G. S. Ang, J. P. Kersey, L. Shepstone, and D. C. Broadway, “The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: a randomised controlled trial,” British Journal of Ophthalmology, vol. 92, no. 8, pp. 1129–1133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Sawada, T. Yamamoto, and N. Takatsuka, “Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 1, pp. 123–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Hashimoto, T. Hara, Y. Takahashi, S. Kubota, M. Kubota, and T. Tsuru, “Hypotensive effect of timolol and latanoprost instillation in normal-tension glaucoma,” Nihon Ganka Gakkai Zasshi, vol. 108, no. 8, pp. 477–481, 2004. View at Google Scholar
  15. B. Pajic, B. Pajic-Eggspuehler, and I. O. Häfliger, “Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma,” Current Medical Research and Opinion, vol. 26, no. 9, pp. 2213–2219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. G. P. Konstas, K. Boboridis, D. Tzetzi, K. Kallinderis, J. N. Jenkins, and W. C. Stewart, “Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy,” Archives of Ophthalmology, vol. 123, no. 7, pp. 898–902, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. A. Hughes, J. Bacharach, E. R. Craven et al., “A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension,” Journal of Glaucoma, vol. 14, no. 5, pp. 392–399, 2005. View at Google Scholar
  18. J. S. Schuman, G. J. Katz, R. A. Lewis et al., “Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension,” The American Journal of Ophthalmology, vol. 140, no. 2, pp. 242–250, 2005. View at Google Scholar
  19. D. R. Anderson, S. M. Drance, and M. Schulzer, “The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma,” The American Journal of Ophthalmology, vol. 126, no. 4, pp. 498–505, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. C. Leske, A. Heijl, M. Hussein, B. Bengtsson, L. Hyman, and E. Komaroff, “Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial,” Archives of Ophthalmology, vol. 121, no. 1, pp. 48–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Cucherat, I. Stalmans, and J.-F. Rouland, “Relative efficacy and safety of preservative-free latanoprost (T2345) for the treatment of open-angle glaucoma and ocular hypertension: an adjusted indirect comparison meta-analysis of randomized clinical trials,” Journal of Glaucoma, vol. 23, no. 1, pp. e69–e75, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Aihara, H. Oshima, and M. Araie, “Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface—a multicentre randomized single-masked study,” Acta Ophthalmologica, vol. 91, no. 1, pp. e7–e14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kanamoto, Y. Kiuchi, I. Ichioka et al., “Clinical efficacy of travoprost-timolol fixed combination on ocular hypotensive agents and ocular surface agents in Japanese glaucoma patients,” Nihon Ganka Gakkai Zasshi, vol. 117, no. 10, pp. 793–798, 2013 (Japanese). View at Google Scholar · View at Scopus